Why LRMR? Larimar Therapeutics, Inc. Analysis, Price & AI Insights | Whystock
LRMR
$4.22+0.28 (+7.11%)
After Hours$4.22+0.00 (+0.00%)· Last close May 4
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform.